Approval · Notice of Compliance 22928 · 2019
ADVIL COLD & SINUS PLUS: Notice of Compliance 22928
Issued November 21, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22928
- Date
- November 21, 2019
- Company
- Pfizer Consumer Healthcare, a division of Pfizer Canada ULCMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates to comply with the plain language labelling regulations. updated warnings for ibuprofen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL COLD & SINUS PLUS | Not yet assigned | — |
| ADVIL COLD, SINUS & FLU EXTRA STRENGTH | Not yet assigned | — |
| CHILDREN'S ADVIL COLD & FLU MULTI-SYMPTOM | 02268701 | Dormant |
Medicinal ingredients
- CHLORPHENIRAMINE MALEATE 2 MG per TAB
- IBUPROFEN 200 MG per TAB
- PSEUDOEPHEDRINE HCL 30 MG per TAB
- CHLORPHENIRAMINE MALEATE 4 MG per TAB
- IBUPROFEN 400 MG per TAB
- PSEUDOEPHEDRINE HCL 60 MG per TAB
- CHLORPHENIRAMINE MALEATE 1 MG per 5ML
- IBUPROFEN 100 MG per 5ML
- PSEUDOEPHEDRINE HCL 15 MG per 5ML